Takeda Pharmaceutical Co. Ltd. - Price To Cashflow Ratio

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Price-To-Cashflow-Ratio" stands at 5.95 as of 09/30/2025, the lowest value since 03/31/2023.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Price To Cashflow Ratio" stands at 5.95. This represents a decrease of -9.85 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -24.25 percent compared to the value the year prior.
The 1 year change in percent is -24.25.
The 3 year change in percent is 5.26.

The Serie's long term average value is 6.73. It's latest available value, on 09/30/2025, is 11.59 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +28.81%.
The Serie's change in percent from it's maximum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is -34.37%.